557
Participants
Start Date
January 31, 2013
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
Vildagliptin
Patients will be instructed to take Vildagliptin tablets at a fixed dose of 50 mg twice daily (double blind therapy)
Gliclazide
Patients will be instructed to take Gliclazide capsules at an equivalent dose to previous sulfonylurea in multiples of 80mg only (double blind therapy)
Metformin
Patients in both arms will take Metformin at a dose between 1500mg-2500mg per day, in an open label fashion
Placebo to Gliclazide
Patients will be instructed to take the Gliclazide matching placebo capsules at an equivalent dose to previous sulfonylurea in multiples of 80mg only (double blind therapy)
Placebo to Vildagliptin
Patients will be instructed to take Vildagliptin matching placebo tablets at a fixed dose of 50 mg twice daily (double blind therapy).
Novartis Investigative Site, Hazmiyeh
Novartis Investigative Site, Le Belvedere - Tunis
Novartis Investigative Site, Tunis
Novartis Investigative Site, Tunis
Novartis Investigative Site, Kuwait City
Novartis Investigative Site, Frederiksberg
Novartis Investigative Site, Sfax
Novartis Investigative Site, Sousse
Novartis Investigative Site, Monastir
Novartis Investigative Site, Jakarta
Novartis Investigative Site, Jakarta
Novartis Investigative Site, Berlin
Novartis Investigative Site, Amman
Novartis Investigative Site, Riyadh
Novartis Investigative Site, Cairo
Novartis Investigative Site, Kota Bharu
Novartis Investigative Site, Girona
Novartis Investigative Site, Salt
Novartis Investigative Site, Alexandria
Novartis Investigative Site, Padang
Novartis Investigative Site, Málaga
Novartis Investigative Site, Bad Oeynhausen
Novartis Investigative Site, Löhne
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Novartis Investigative Site, Einbeck
Novartis Investigative Site, Meine
Novartis Investigative Site, Dammam
Novartis Investigative Site, Dortmund
Novartis Investigative Site, Kahramanmaraş
Novartis Investigative Site, Ceuta
Novartis Investigative Site, Melilla
Novartis Investigative Site, Kuala Lumpur
Novartis Investigative Site, Surabaya
Novartis Investigative Site, Malang
Novartis Investigative Site, Saarlouis
Novartis Investigative Site, München
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Rostov-on-Don
Novartis Investigative Site, Rostov-on-Don
Novartis Investigative Site, Krasnodar
Novartis Investigative Site, Saratov
Novartis Investigative Site, Penza
Novartis Investigative Site, Singapore
Novartis Investigative Site, Ufa
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Beirut
Novartis Investigative Site, Beirut
Novartis Investigative Site, Saida
Novartis Investigative Site, Tunis
Novartis Investigative Site, Dubai
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Santa Coloma de Gramanet
Novartis Investigative Site, Vic
Novartis Investigative Site, Diskapi / Ankara
Novartis Investigative Site, Leicester
Novartis Investigative Site, London
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Bolton
Novartis Investigative Site, Derby
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY